Jiwoong Her

Dr. Jiwoong Her

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 August 2020 in Frontiers in Veterinary Science
Verified
Journal Article
Open access
PDF file
JHJiwoong Her
Jiwoong Her
KKKendon W. Kuo
Kendon W. Kuo
RWRandolph L. Winter
Randolph L. Winter
CCCrisanta Cruz-Espindola
Crisanta Cruz-Espindola
LBLenore M. Bacek
Lenore M. Bacek
DBDawn M. Boothe
Dawn M. Boothe
Objective: This study describes the pharmacokinetics of parent pimobendan (PIM) and its active metabolite, o-desmethyl-pimobendan (ODMP), after oral and rectal administration of pimobendan to healthy dogs. Animals: A total of eight healthy privately owned dogs were used in this study. Procedures: The dogs received a single dose (0.5 mg/kg) of a commercially available pimobendan tablet per os (PO). Twelve blood samples were collected over a 12-h period for pharmacokinetic analysis. After a 24-h washout period, the dogs received the same dose of pimobendan solution per rectum (PR), and samples were obtained at the same time for analysis. Results: For PIM, PO vs. PR, respectively, the mean maximum plasma concentration (Cmax, ng/ml) was 49.1 ± 28.7 vs. 10.1 ± 2, the time to reach a maximum concentration (Tmax, h) was 2.1 ± 0.9 vs. 1 ± 0.4, the disappearance half-life (t1/2, h) was 1.8 ± 0.8 vs. 2.2 ± 0.6, and the area under the concentration–time curve (AUC, ng*h/ml) was 148.4 ± 71.6 vs. 31.1 ± 11.9, with relative bioavailability (F, %) of 25 ± 8. For ODMP, PO vs. PR, respectively, Cmax was 30.9 ± 10.4 vs. 8.8 ± 4.8, Tmax was 3.2 ± 1.6 vs. 1.7 ± 1.1, and t1/2 was 5.0 ± 2.7 vs. 8.3 ± 4.8, with AUC of 167.8 ± 36.2 vs. 50.1 ± 19.2 and F of 28 ± 6. The differences between PO and PR were significant (P < 0.03) for AUC and Cmax for both PIM and ODMP. Conclusions and Clinical Relevance: The pharmacokinetics of PIM and ODMP were described following PO and PR administration. The findings suggest that pimobendan PR might achieve effective concentrations and, as such, warrant future studies of clinical effectiveness in treating dogs with congestive heart failure and which are unable to receive medication PO.

5 October 2021 in Journal of Veterinary Emergency and Critical Care
Verified
Journal Article
Closed access
PDF file
JHJiwoong Her
Jiwoong Her
AYAmy B. Yanke
Amy B. Yanke
KGKatherine Gerken
Katherine Gerken
JYJin Yoon
Jin Yoon
APAshley Antonia Peters
Ashley Antonia Peters
KKKendon W. Kuo
Kendon W. Kuo

1 July 2025 in Journal of Veterinary Internal Medicine
Verified
Journal Article
Open access
JLJeongmin Lee
Jeongmin Lee
KYKyoung-A Youp
Kyoung-A Youp
SLSun-Tae Lee
Sun-Tae Lee
ALAh-Ra Lee
Ah-Ra Lee
YCYoung-Wook Cho
Young-Wook Cho
SLSeung-Keun Lee
Seung-Keun Lee
Background: Transcatheter edge-to-edge repair (TEER) is an emerging minimally invasive mitral valve repair treatment for dogs with myxomatous mitral valve disease (MMVD), but reports on its outcomes are limited. Objective: Describe the clinical characteristics and complications in dogs with MMVD undergoing TEER. Animals: Twenty client-owned dogs with MMVD stages B2, C, and D. Methods: Retrospective case series. Cases were identified by review of hospital medical records between September 2023 and September 2024. Results: Twenty dogs underwent TEER; of these, 13 (65%) survived. Seven dogs died within 9 days because of mitral leaflet tear or single-leaflet device attachment (4/7 dogs, 57.1%), tracheal collapse (1/7 dogs, 14.3%), presumed post-procedure neurologic deficit with a history of hydrocephalus (1/7 dogs, 14.3%), and presumed cardiogenic shock (1/7 dogs, 14.3%). Significant reductions in vertebral heart score (11.6 [9.6–13.1] vs. 11.0 [8.3–11.9] vertebrae; p < 0.01), vertebral left atrial size (2.90 [2.1–3.6] vs. 2.60 [2.0–3.3] vertebrae; p < 0.01), left atrium-to-aortic root ratio (2.09 [1.5–2.5] vs. 1.69 [1.3–2.2]; p < 0.05), left ventricular end-diastolic diameter normalized for body weight (2.1 [1.5–2.3] vs. 1.76 [1.4–2.2]; p < 0.05), regurgitant fraction (77.83 [73.2–83.0] vs. 55.38 [20.5–73.6] %; p < 0.05), and regurgitant volume (3.96 [2.1–6.2] vs. 1.25 [0.4–3.5] ml/kg; p < 0.05) were observed 3 months after TEER. Conclusions and Clinical Importance: Transcatheter edge-to-edge repair resulted in a significant reduction in left atrium and ventricle size and should be further investigated as a potential treatment option for dogs with MMVD.

6 October 2021 in Journal of Feline Medicine and Surgery
Verified
Journal Article
Closed access
PDF file
JHJiwoong Her
Jiwoong Her
YMYael Merbl
Yael Merbl
KGKatherine Gerken
Katherine Gerken
MKMinjeong Kim
Minjeong Kim
EHErik Hofmeister
Erik Hofmeister
AYAmy B Yanke
Amy B Yanke
Objectives: The aim of the study was to evaluate whether any admission vitals correlated with the presence of brain herniation diagnosed via MRI in cats presenting with neurologic signs. Methods: Medical records at two veterinary university referral centers were reviewed to identify cats that underwent brain MRI between 2010 and 2019. A control group of cats with intracranial lesions without concurrent brain herniation was analyzed for comparison. Data relating to signalment, vitals on admission, abnormalities observed on initial neurologic examination, underlying etiology, advanced imaging findings and outcome were reviewed. A Modified Glasgow Coma Scale (MGCS) score was determined retrospectively based on initial neurologic examination. Logistic regressions were performed to investigate the relationship between each risk factor and the odds of brain herniation as diagnosed on MRI. Results: Thirty-two cats with brain herniation and 44 cats with abnormal brain MRI without evidence of herniation (as a control group) based on MRI findings were included. Cats with intracranial neoplasia vs other diagnoses were found to be at increased risk of herniation (odds ratio [OR] 4.8, 95% confidence interval [CI] 1.8–13.8; P = 0.001). The odds of herniation increased with age (OR 1.1, 95% CI 1.01–1.2; P = 0.031). Cats with herniation had a significantly lower level of consciousness in their MGCS score ( P 0.05). Conclusions and relevance: Admission heart rate and blood pressure were not associated with brain herniation. Cats with herniation were presented with a significantly lower level of consciousness in their MGCS score; however, this clinical feature cannot be directly attributable to and predictive of herniation. Older cats with intracranial neoplasia are more likely to have brain herniation.

1 July 2023 in Journal of Feline Medicine and Surgery Open Reports
Verified
Journal Article
Open access
CPCéline Pouzot-Nevoret
Céline Pouzot-Nevoret
LHLeïla Hocine
Leïla Hocine
BABernard Allaouchiche
Bernard Allaouchiche
JHJiwoong Her
Jiwoong Her
Case summary: A 7-month-old female spayed domestic shorthair cat was presented for respiratory distress due to cardiogenic pulmonary edema. Despite initial treatment and oxygen delivery in an oxygen tent, the cat still showed signs of severe respiratory effort and oxygen saturation measured via pulse oximetry was below 85%. Because the owners declined mechanical ventilation, the cat was transitioned to high-flow oxygen therapy (HFOT). HFOT allowed significant improvement of the respiration parameters within 15 mins without causing clinical complications. The cat was briefly anaesthetised for the placement of the nasal cannula on initiation of HFOT, and the interface was well tolerated thereafter. The cat was transitioned to an oxygen cage after 16 h, weaned from oxygen 4 h later and was discharged after 3 days of hospitalisation. Long-term follow-up showed no abnormalities, and the leading hypothesis was transient myocardial thickening. Relevance and novel information: The first use of HFOT in a dyspneic cat is described in this study. HFOT could be a life-saving option for cats with severe hypoxemia or do-not-intubate orders that fail to respond to conventional oxygen therapies.

7 May 2024 in Frontiers in Veterinary Science
Verified
Journal Article
Open access
EDErin Duble
Erin Duble
JHJiwoong Her
Jiwoong Her
IPIngrid Preteseille
Ingrid Preteseille
JLJeongmin Lee
Jeongmin Lee
BABernard Allaouchiche
Bernard Allaouchiche
CPCéline Pouzot-Nevoret
Céline Pouzot-Nevoret
Objective: This study aims to evaluate the respiratory rate-oxygenation index (ROX) and the ratio of pulse oximetry saturation (SpO2) to the fraction of inspired oxygen (FiO2) (SpO2/FiO2, [SF]) to determine whether these indices are predictive of outcome in dogs receiving high-flow nasal cannula oxygen therapy (HFNOT).Design: This is a prospective observational study.Setting: This study was carried out at two university teaching hospitals.Animals: In total, 88 dogs treated with HFNOT for hypoxemic respiratory failure due to various pulmonary diseases were selected.Measurements and main results: The ROX index was defined as the SF divided by the respiratory rate (RR). ROX and SF were calculated at baseline and for each hour of HFNOT. The overall success rate of HFNOT was 38% (N = 33/88). Variables predicting HFNOT success were determined using logistic regression, and the predictive power of each variable was assessed using the area under the receiver operating curve (AUC). ROX and SF were adequately predictive of HFNOT success when averaged over 0–16 h of treatment, with similar AUCs of 0.72 (95% confidence interval [CI] 0.60–0.83) and 0.77 (95% CI 0.66–0.87), respectively (p < 0.05). SF showed acceptable discriminatory power in predicting HFNOT outcome at 7 h, with an AUC of 0.77 (95% CI 0.61–0.93, p = 0.013), and the optimal cutoff for predicting HFNC failure at 7 h was SF ≤ 191 (sensitivity 83% and specificity 76%).Conclusion: These indices were easily obtained in dogs undergoing HFNOT. The results suggest that ROX and SF may have clinical utility in predicting the outcomes of dogs on HFNOT. Future studies are warranted to confirm these findings in a larger number of dogs in specific disease populations.